Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment

Table 1 Select self-report participant characteristics at initial iOAT entry

Characteristics	N = 30
Characteristics	M ± SD; n (%)
Socio-demographic characteristics
Age	44.7 ± 8.7
Women	14 (46.7)
Any Indigenous vs. Non-Indigenous ancestry ^a	7 (23.3)
Any non-stable housing in prior 3 years vs. none	19 (63.3)
Any street housing in prior 3 years vs. none	6 (20.00)
Education
Less than high-school certificate	10 (33.3)
High school certificate	7 (23.3)
High school certificate and higher (e.g., trades, university)	13 (43.3)
Health status
Physical health score ^b	13.8 ± 8.0
Psychological health score ^b	9.5 ± 8.0
Health related quality of life score ^c	0.8 ± 0.2
Susbstance use and substance use treatment history
Lifetime years heroin injection	14.5 ± 8.6
Times ever attempted medication assisted treatment with oral methadone	4.2 ± 2.6
Highest daily dose of oral methadone in mgs ^d	106.7 ± 51.9
Ever enrolled in outpatient withdrawal	28 (93.3)
Ever in outpatient counseling	23 (76.7)
Ever enrolled in residential treatment	17 (56.7)

Data shown are mean ± standard deviation; N (%)
^aAboriginal ancestry includes participants who self-identified as Inuit, Metis, or First Nations.
^bMAP Physical and Psychological health scores range from 0 to 40 with higher scores indicating poorer health.
^cEQ5D (Euroquol) with Canadian weights scores range from 0 to 1; higher scores are indicative of better health status.
^dBased on administrative prescription records data from 1995 to 2012.